Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • State of the Art
  • Published:

State-of-the-Art

Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?

Journal of Perinatology volume 30, pages 241–252 (2010)Cite this article

Subjects

Abstract

Medical and surgical interventions are widely used to close a persistently patent ductus arteriosus in preterm infants. Objective evidence to support these practices is lacking, causing some to question their usage. Emerging evidence suggests that treatments that close the patent ductus may be detrimental. This review examines the history of and evidence underlying these treatments. Neither individual trials, pooled data from groups of randomized-controlled trials, nor critical examination of the immediate consequences of treatment provide evidence that medical or surgical closure of the ductus is beneficial in preterm infants. These conclusions are supported by sufficient evidence. Neither continued routine use of these treatments nor additional clinical trials using similar designs seems to be justified. A definitive trial, comparing current standard management with novel strategies not primarily intended to achieve ductal closure, may be necessary to resolve doubts regarding the quality or conduct of prior studies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

References

  1. Burnard ED . The cardiac murmur in relation to symptoms in the newborn. Br Med J 1959; 1: 134–138.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Northway Jr WH, Rosan RC, Porter DY . Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357–368.

    Article  PubMed  Google Scholar 

  3. Siassi B, Emmanouilides GC, Cleveland RJ, Hirose F . Patent ductus arteriosus complicating prolonged assisted ventilation in respiratory distress syndrome. J Pediatr 1969; 74: 11–19.

    Article  CAS  PubMed  Google Scholar 

  4. Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK . Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med 1971; 284: 1333–1340.

    Article  CAS  PubMed  Google Scholar 

  5. Kitterman JA, Edmunds Jr LH, Gregory GA, Heymann MA, Tooley WH, Rudolph AM . Patent ducts arteriosus in premature infants. Incidence, relation to pulmonary disease and management. N Engl J Med 1972; 287: 473–477.

    Article  CAS  PubMed  Google Scholar 

  6. Finlay ER, Subhedar NV . Pulmonary haemorrhage in preterm infants. Eur J Pediatr 2000; 159: 870–871.

    Article  CAS  PubMed  Google Scholar 

  7. Kluckow M, Evans N . Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 2000; 137: 68–72.

    Article  CAS  PubMed  Google Scholar 

  8. Jones RW, Pickering D . Persistent ductus arteriosus complicating the respiratory distress syndrome. Arch Dis Child 1977; 52: 274–281.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Jacob J, Gluck L, DiSessa T, Edwards D, Kulovich M, Kurlinski J et al. The contribution of PDA in the neonate with severe RDS. J Pediatr 1980; 96: 79–87.

    Article  CAS  PubMed  Google Scholar 

  10. Marshall DD, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM . Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics 1999; 104: 1345–1350.

    Article  CAS  PubMed  Google Scholar 

  11. Redline RW, Wilson-Costello D, Hack M . Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res 2002; 52: 713–719.

    Article  PubMed  Google Scholar 

  12. Oh W, Poindexter BB, Perritt R, Lemons JA, Bauer CR, Ehrenkranz RA et al. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. J Pediatr 2005; 147: 786–790.

    Article  PubMed  Google Scholar 

  13. Ryder RW, Shelton JD, Guinan ME . Necrotizing enterocolitis: a prospective multicenter investigation. Am J Epidemiol 1980; 112: 113–123.

    Article  CAS  PubMed  Google Scholar 

  14. Dollberg S, Lusky A, Reichman B . Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr 2005; 40: 184–188.

    Article  CAS  PubMed  Google Scholar 

  15. Vanpee M, Ergander U, Herin P, Aperia A . Renal function in sick, very low-birth-weight infants. Acta Paediatr 1993; 82: 714–718.

    Article  CAS  PubMed  Google Scholar 

  16. Dykes FD, Lazzara A, Ahmann P, Blumenstein B, Schwartz J, Brann AW . Intraventricular hemorrhage: a prospective evaluation of etiopathogenesis. Pediatrics 1980; 66: 42–49.

    CAS  PubMed  Google Scholar 

  17. Evans N, Kluckow M . Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996; 75: F183–F186.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Shortland DB, Gibson NA, Levene MI, Archer LN, Evans DH, Shaw DE . Patent ductus arteriosus and cerebral circulation in preterm infants. Dev Med Child Neurol 1990; 32: 386–393.

    Article  CAS  PubMed  Google Scholar 

  19. Drougia A, Giapros V, Krallis N, Theocharis P, Nikaki A, Tzoufi M et al. Incidence and risk factors for cerebral palsy in infants with perinatal problems: a 15-year review. Early Hum Dev 2007; 83: 541–547.

    Article  CAS  PubMed  Google Scholar 

  20. Dudell GG, Gersony WM . Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr 1984; 104: 915–920.

    Article  CAS  PubMed  Google Scholar 

  21. Cotton RB, Stahlman MT, Kovar I, Catterton WZ . Medical management of small preterm infants with symptomatic patent ductus arteriosus. J Pediatr 1978; 92: 467–473.

    Article  CAS  PubMed  Google Scholar 

  22. Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K . Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 2005; 90: F235–F239.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 2009; 123: e138–e144.

    Article  PubMed  Google Scholar 

  24. Edmunds Jr LH, Gregory GA, Heymann MA, Kitterman JA, Rudolph AM, Tooley WH . Surgical closure of the ductus arteriosus in premature infants. Circulation 1973; 48: 856–863.

    Article  PubMed  Google Scholar 

  25. Gupta JM, Van Vliet PK, Fisk GC, Wright JS . Ductus ligation in respiratory distress syndrome. J Thorac Cardiovasc Surg 1972; 63: 642–647.

    CAS  PubMed  Google Scholar 

  26. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE . Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med 1976; 295: 526–529.

    Article  CAS  PubMed  Google Scholar 

  27. Heymann MA, Rudolph AM, Silverman NH . Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976; 295: 530–533.

    Article  CAS  PubMed  Google Scholar 

  28. Kitterman JA . Patent ductus arteriosus: current clinical status. Arch Dis Child 1980; 55: 106–109.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS . Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983; 102: 895–906.

    Article  CAS  PubMed  Google Scholar 

  30. Peckham GJ, Miettinen OS, Ellison RC, Kraybill EN, Gersony WM, Zierler S et al. Clinical course to 1 year of age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin. J Pediatr 1984; 105: 285–291.

    Article  CAS  PubMed  Google Scholar 

  31. Knight DB . The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 2001; 6: 63–73.

    Article  CAS  PubMed  Google Scholar 

  32. Bose CL, Laughon MM . Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 2007; 92: F498–F502.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Van Overmeire B . Patent ductus arteriosus: how aggressive should we be? Neonatology 2007; 91: 318.

    Article  Google Scholar 

  34. Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A . Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007; 150: 229–234, 234 e221.

    Article  CAS  PubMed  Google Scholar 

  35. Chorne N, Leonard C, Piecuch R, Clyman RI . Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 2007; 119: 1165–1174.

    Article  PubMed  Google Scholar 

  36. Clyman R, Cassady G, Kirklin JK, Collins M, Philips III JB . The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr 2009; 154: 873–876.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Hammerman C, Aramburo MJ . Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus. J Pediatr 1990; 117: 771–776.

    Article  CAS  PubMed  Google Scholar 

  38. Lee J, Rajadurai VS, Tan KW, Wong KY, Wong EH, Leong JY . Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants. Pediatrics 2003; 112: 345–350.

    Article  PubMed  Google Scholar 

  39. Rennie JM, Cooke RW . Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity. Arch Dis Child 1991; 66: 55–58.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Rhodes PG, Ferguson MG, Reddy NS, Joransen JA, Gibson J . Effects of prolonged versus acute indomethacin therapy in very low birth-weight infants with patent ductus arteriosus. Eur J Pediatr 1988; 147: 481–484.

    Article  CAS  PubMed  Google Scholar 

  41. Tammela O, Ojala R, Iivainen T, Lautamatti V, Pokela ML, Janas M et al. Short versus prolonged indomethacin therapy for patent ductus arteriosus in preterm infants. J Pediatr 1999; 134: 552–557.

    Article  CAS  PubMed  Google Scholar 

  42. Adamska E, Helwich E, Rutkowska M, Zacharska E, Piotrowska A . Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants. Med Wieku Rozwoj 2005; 9: 335–354.

    PubMed  Google Scholar 

  43. Akisu M, Ozyurek AR, Dorak C, Parlar A, Kultursay N . Enteral ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm newborn infants [Premature bebeklerde patent duktus arteriozusun tedavisinde enteral ibuprofen ve indometazinin etkinligi ve guvenilirligi]. Cocuk Sagligi ve Hastaliklari Dergisi 2001; 44: 56–60.

    Google Scholar 

  44. Aly H, Lotfy W, Badrawi N, Ghawas M, Abdel-Meguid IE, Hammad TA . Oral Ibuprofen and ductus arteriosus in premature infants: a randomized pilot study. Am J Perinatol 2007; 24: 267–270.

    Article  PubMed  Google Scholar 

  45. Chotigeat U, Jirapapa K, Layangkool T . A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai 2003; 86 (Suppl 3): S563–S569.

    PubMed  Google Scholar 

  46. Fakhraee SH, Badiee Z, Mojtahedzadeh S, Kazemian M, Kelishadi R . Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi 2007; 9: 399–403.

    PubMed  Google Scholar 

  47. Gimeno Navarro A, Cano Sanchez A, Fernandez Gilino C, Carrasco Moreno J, Izquierdo Macian I, Gutierrez Laso A et al. Ibuprofen versus indomethacin in the treatment of patent ductus arteriosus in preterm infants [Ibuprofeno frente a indometacina en el tratamiento del conducto arterioso persistente del prematuro]. Anales de Pediatria 2005; 63: 212–218.

    Article  CAS  PubMed  Google Scholar 

  48. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 2002; 161: 202–207.

    Article  CAS  PubMed  Google Scholar 

  49. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C . Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997; 131: 549–554.

    Article  CAS  PubMed  Google Scholar 

  50. Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD . Ibuprofen treatment of patent ductus arteriosus. Lancet 1995; 346: 255.

    Article  CAS  PubMed  Google Scholar 

  51. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD . Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000; 47: 36–42.

    Article  CAS  PubMed  Google Scholar 

  52. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF . Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999; 135: 733–738.

    Article  CAS  PubMed  Google Scholar 

  53. Plavka R, Svihovek P, Borek I, Biolek J, Kostirova M, Liska K et al. Ibuprofen vs. indomethacin in the treatment of patent ductus arteriosus (PDA) in very premature neonates. Pediatr Res 2001; 49: 375A.

    Google Scholar 

  54. Su BH, Lin HC, Chiu HY, Hsieh HY, Chen HH, Tsai YC . Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2008; 93: F94–F99.

    Article  PubMed  Google Scholar 

  55. Su PH, Chen JY, Su CM, Huang TC, Lee HS . Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatr Int 2003; 45: 665–670.

    Article  CAS  PubMed  Google Scholar 

  56. Supapannachart S, Limrungsikul A, Khowsathit P . Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai 2002; 85 (Suppl 4): S1252–S1258.

    PubMed  Google Scholar 

  57. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ . Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed 1997; 76: F179–F184.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Van Overmeire B, Follens I, Hatrtmann S, Mahieu L, Van Reempts PJ . Intravenous ibuprofen (IBU) for the treatment of patent ductus arterosius (PDA) in patients with respiratory distress syndrome (RDS). Pediatr Res 1996; 39: 250A.

    Article  Google Scholar 

  59. Van Overmeire B, Langhendries JP, Van Haesebrouck P, Lecoutere D, Van de Broek H . Ibuprofen for early treatment of patent ductus arterosius, a randomized multicentre trial. Pediatr Res 1998; 43: 200A.

    Google Scholar 

  60. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000; 343: 674–681.

    Article  CAS  PubMed  Google Scholar 

  61. Osborn DA, Evans N, Kluckow M . Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant. Arch Dis Child Fetal Neonatal Ed 2003; 88: F477–F482.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I . Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 1978; 93: 647–651.

    Article  CAS  PubMed  Google Scholar 

  63. Levitsky S, Fisher E, Vidyasagar D, Hastreiter AR, Bennett E, Raju TN et al. Interruption of patent ductus arteriosus in premature infants with respiratory distress syndrome. Ann Thorac Surg 1976; 22: 131–137.

    Article  CAS  PubMed  Google Scholar 

  64. Cassady G, Crouse DT, Kirklin JW, Strange MJ, Joiner CH, Godoy G et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med 1989; 320: 1511–1516.

    Article  CAS  PubMed  Google Scholar 

  65. Nestrud RM, Hill DE, Arrington RW, Beard AG, Dungan WT, Lau PY et al. Indomethacin treatment in patent ductus arteriosus. A double-blind study utilizing indomethacin plasma levels. Dev Pharmacol Ther 1980; 1: 125–136.

    Article  CAS  PubMed  Google Scholar 

  66. Valaes T, Moylan FMB, Cohn H, Chung K, Nagpaul K, Chrenoff HI et al. Incidence and significance of PDA in preterm infants (PTI) and controlled trial of indomethacin. Pediatr Res 1980; 14: 452.

    Article  Google Scholar 

  67. Neu J, Ariagno RL, Johnson JD, Pitlick PT, Cohen RS, Beets CL et al. A double blind study of the effects of oral indomethacin in preterm infants with patent ductus arteriosus who failed medical management. Pediatr Pharmacol (New York) 1981; 1: 245–249.

    CAS  Google Scholar 

  68. Yanagi RM, Wilson A, Newfeld EA, Aziz KU, Hunt CE . Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study. Pediatrics 1981; 67: 647–652.

    CAS  PubMed  Google Scholar 

  69. Mullett MD, Croghan TW, Myerberg DZ, Krall JM, Neal WA . Indomethacin for closure of patent ductus arteriosus in prematures. Clin Pediatr (Phila) 1982; 21: 217–220.

    Article  CAS  Google Scholar 

  70. Kaapa P, Lanning P, Koivisto M . Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatr Scand 1983; 72: 179–184.

    Article  CAS  PubMed  Google Scholar 

  71. Rudd P, Montanez P, Hallidie-Smith K, Silverman M . Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial. Arch Dis Child 1983; 58: 267–270.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Vogtmann C, Grubbe G, Ruckhaberle KE, Bottcher H, Ockert C . Effects of early therapy with indomethacin on the manifestation of a persistent ductus arteriosus in extremely underweight premature infants. Monatsschr Kinderheilkd 1988; 136: 636–639.

    CAS  PubMed  Google Scholar 

  73. Lai TH, Soong WJ, Hwang B . Indomethacin for the prevention of symptomatic patent ductus arteriosus in very low birth weight infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1990; 31: 17–23.

    CAS  PubMed  Google Scholar 

  74. Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI . Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med 1982; 306: 506–510.

    Article  CAS  PubMed  Google Scholar 

  75. Hammerman C, Strates E, Valaitis S . The silent ductus: its precursors and its aftermath. Pediatr Cardiol 1986; 7: 121–127.

    Article  CAS  PubMed  Google Scholar 

  76. Weesner KM, Dillard RG, Boyle RJ, Block SM . Prophylactic treatment of asymptomatic patent ductus arteriosus in premature infants with respiratory distress syndrome. South Med J 1987; 80: 706–708.

    Article  CAS  PubMed  Google Scholar 

  77. Cotton RB, Hickey DE, Graham TP, Stahlman MT . Effect of early indomethacin on ventilatory status of preterm infants with symptomatic patent ductus arteriosus [abstract]. Pediatr Res 1980; 14: 442.

    Google Scholar 

  78. Merritt TA, Harris JP, Roghmann K, Wood B, Campanella V, Alexson C et al. Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial. J Pediatr 1981; 99: 281–286.

    Article  CAS  PubMed  Google Scholar 

  79. Yeh TF, Goldbarg HR, Henek T, Thalji A, Pildes RS . Intravenous indomethacin therapy in premature infants with patent ductus arteriosus. Causes of death and one-year follow-up. Am J Dis Child 1982; 136: 803–807.

    Article  CAS  PubMed  Google Scholar 

  80. Yeh TF, Luken JA, Thalji A, Raval D, Carr I, Pildes RS . Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus—a double-blind controlled study. J Pediatr 1981; 98: 137–145.

    Article  CAS  PubMed  Google Scholar 

  81. Monset-Couchard M, Dias-Mancano D, Murat I, Relier JP . Controlled trial of intravenous lyophilized indomethacin in the treatment of persistent ductus arteriosus in premature infants. Pediatrie 1983; 38: 365–377.

    CAS  PubMed  Google Scholar 

  82. Krauss AN, Fatica N, Lewis BS, Cooper R, Thaler HT, Cirrincione C et al. Pulmonary function in preterm infants following treatment with intravenous indomethacin. Am J Dis Child 1989; 143: 78–81.

    CAS  PubMed  Google Scholar 

  83. Van Overmeire B, Van de Broek H, Van Laer P, Weyler J, Vanhaesebrouck P . Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 2001; 138: 205–211.

    Article  CAS  PubMed  Google Scholar 

  84. Dani C, Bertini G, Pezzati M, Poggi C, Guerrini P, Martano C et al. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter, randomized study. Pediatrics 2005; 115: 1529–1535.

    Article  PubMed  Google Scholar 

  85. Dani C, Bertini G, Reali MF, Murru P, Fabris C, Vangi V et al. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta Paediatr 2000; 89: 1369–1374.

    Article  CAS  PubMed  Google Scholar 

  86. De Carolis MP, Romagnoli C, Polimeni V, Piersigilli F, Zecca E, Papacci P et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr 2000; 159: 364–368.

    Article  CAS  PubMed  Google Scholar 

  87. Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 1939–1944.

    Article  CAS  PubMed  Google Scholar 

  88. Van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluwe W, Jespers A et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 1945–1949.

    Article  CAS  PubMed  Google Scholar 

  89. Aranda JV, Clyman R, Cox B, Van Overmeire B, Wozniak P, Sosenko I et al. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol 2009; 26: 235–245.

    Article  PubMed  Google Scholar 

  90. Mahony L, Caldwell RL, Girod DA, Hurwitz RA, Jansen RD, Lemons JA et al. Indomethacin therapy on the first day of life in infants with very low birth weight. J Pediatr 1985; 106: 801–805.

    Article  CAS  PubMed  Google Scholar 

  91. Ment LR, Duncan CC, Ehrenkranz RA, Kleinman CS, Pitt BR, Taylor KJ et al. Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. J Pediatr 1985; 107: 937–943.

    Article  CAS  PubMed  Google Scholar 

  92. Puckett CG, Cox MA, Haskins KS, Fisher DJ . Prophylactic indomethacin for the prevention of patent ductus arteriosus. Pediatr Res 1985; 19: 358.

    Article  Google Scholar 

  93. Rennie JM, Doyle J, Cooke RW . Early administration of indomethacin to preterm infants. Arch Dis Child 1986; 61: 233–238.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Krueger E, Mellander M, Bratton D, Cotton R . Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin. J Pediatr 1987; 111: 749–754.

    Article  CAS  PubMed  Google Scholar 

  95. Vincer M, Allen A, Evans J, Nwaesei C, Stinson D, Rees E et al. Early intravenous indomethacin prolongs respiratory support in very low birth weight infants. Acta Paediatr Scand 1987; 76: 894–897.

    Article  CAS  PubMed  Google Scholar 

  96. Bandstra ES, Montalvo BM, Goldberg RN, Pacheco I, Ferrer PL, Flynn J et al. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics 1988; 82: 533–542.

    CAS  PubMed  Google Scholar 

  97. Hanigan WC, Kennedy G, Roemisch F, Anderson R, Cusack T, Powers W . Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates. J Pediatr 1988; 112: 941–947.

    Article  CAS  PubMed  Google Scholar 

  98. Ment LR, Duncan CC, Ehrenkranz RA, Kleinman CS, Taylor KJ, Scott DT et al. Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr 1988; 112: 948–955.

    Article  CAS  PubMed  Google Scholar 

  99. Bada HS, Green RS, Pourcyrous M, Leffler CW, Korones SB, Magill HL et al. Indomethacin reduces the risks of severe intraventricular hemorrhage. J Pediatr 1989; 115: 631–637.

    Article  CAS  PubMed  Google Scholar 

  100. Ment LR, Oh W, Ehrenkranz RA, Philip AG, Vohr B, Allan W et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994; 93: 543–550.

    CAS  PubMed  Google Scholar 

  101. Ment LR, Oh W, Ehrenkranz RA, Phillip AG, Vohr B, Allan W et al. Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. J Pediatr 1994; 124: 951–955.

    Article  CAS  PubMed  Google Scholar 

  102. Domanico RS, Waldman JD, Lester LA, McPhillips HA, Catrambone JE, Covert RF . Prophylactic indomethacin reduces the incidence of pulmonary hemorrhage and patent ductus arteriosus in surfactant-treaed infants <1250 g. Pediatr Res 1994; 35: 331A.

    Google Scholar 

  103. Couser RJ, Ferrara TB, Wright GB, Cabalka AK, Schilling CG, Hoekstra RE et al. Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room. J Pediatr 1996; 128: 631–637.

    Article  CAS  PubMed  Google Scholar 

  104. Yaseen H, al Umran K, Ali H, Rustum M, Darwich M, al-Faraidy A . Effects of early indomethacin administration on oxygenation and surfactant requirement in low birth weight infants. J Trop Pediatr 1997; 43: 42–46.

    Article  CAS  PubMed  Google Scholar 

  105. Supapannachart S, Khowsathit P, Patchakapati B . Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams. J Med Assoc Thai 1999; 82 (Suppl 1): S87–S92.

    PubMed  Google Scholar 

  106. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001; 344: 1966–1972.

    Article  CAS  PubMed  Google Scholar 

  107. Kumar Nair PA, Pai MG, Gazal HA, Da Costa DE, Al Khusaiby SM . Indomethacin prophylaxis for intraventricular hemorrhage in very low birth weight babies. Indian Pediatr 2004; 41: 551–558.

    PubMed  Google Scholar 

  108. Gutierrez NG, Lapasset M . Prophylactic indomethacin and the incidence of patent ductus arteriosus in preterm neonates. Proc 3rd Argentinian Congr Perinatol 1987; 62 (as quoted in reference 113).

  109. Morales-Suarez M, Danchez-Gil T, Lemus-Varela L, Udaeta-Mora E . Estudio comparitivo de dosis baja de indometicina profilactica para hemorragia subependimaria/intraventicular en neonatos pretermino con ventilation mechanica. Bol Med Hosp Infant Mex 1994; 51: 389–394.

    Google Scholar 

  110. Alfaleh K, Smyth JA, Roberts RS, Solimano A, Asztalos EV, Schmidt B . Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. Pediatrics 2008; 121: e233–e238.

    Article  PubMed  Google Scholar 

  111. Couser RJ, Hoekstra RE, Ferrara TB, Wright GB, Cabalka AK, Connett JE . Neurodevelopmental follow-up at 36 months' corrected age of preterm infants treated with prophylactic indomethacin. Arch Pediatr Adolesc Med 2000; 154: 598–602.

    Article  CAS  PubMed  Google Scholar 

  112. Ment LR, Vohr B, Allan W, Westerveld M, Sparrow SS, Schneider KC et al. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 2000; 105: 485–491.

    Article  CAS  PubMed  Google Scholar 

  113. Fowlie PW, Davis PG . Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002; CD000174.

  114. Cooke L, Steer P, Woodgate P . Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003; CD003745.

  115. Shah SS, Ohlsson A . Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006; CD004213.

  116. Malviya M, Ohlsson A, Shah S . Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2008; CD003951.

  117. Mosalli R, Alfaleh K . Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev 2008; CD006181.

  118. Ohlsson A, Walia R, Shah S . Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2008; CD003481.

  119. Armitage P, Berry G . Statistical Methods in Medical Research, 3rd edn. Blackwell Science: London, 1994.

    Google Scholar 

  120. Clyman RI . Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J Pediatr 1996; 128: 601–607.

    Article  CAS  PubMed  Google Scholar 

  121. Clyman RI, Chorne N . Patent ductus arteriosus: evidence for and against treatment. J Pediatr 2007; 150: 216–219.

    Article  PubMed  PubMed Central  Google Scholar 

  122. Bose CL, Laughon M . Treatment to prevent patency of the ductus arteriosus: beneficial or harmful? J Pediatr 2006; 148: 713–714.

    Article  PubMed  Google Scholar 

  123. Schmidt B, Roberts RS, Fanaroff A, Davis P, Kirpalani HM, Nwaesei C et al. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr 2006; 148: 730–734.

    Article  CAS  PubMed  Google Scholar 

  124. Powell ML . Patent ductus arteriosus in premature infants. Med J Aust 1963; 2: 58–60.

    CAS  PubMed  Google Scholar 

  125. Auld PA . Delayed closure of the ductus arteriosus. J Pediatr 1966; 69: 61–66.

    Article  CAS  PubMed  Google Scholar 

  126. Danilowicz D, Rudolph AM, Hoffman JI . Delayed closure of the ductus arteriosus in premature infants. Pediatrics 1966; 37: 74–78.

    CAS  PubMed  Google Scholar 

  127. Hallidie-Smith KA . Murmur of persistent ductus arteriosus in premature infants. Arch Dis Child 1972; 47: 725–730.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  128. Clarkson PM, Orgill AA . Continuous murmurs in infants of low birth weight. J Pediatr 1974; 84: 208–211.

    Article  CAS  PubMed  Google Scholar 

  129. Siassi B, Blanco C, Cabal LA, Coran AG . Incidence and clinical features of patent ductus arteriosus in low-birthweight infants: a prospective analysis of 150 consecutively born infants. Pediatrics 1976; 57: 347–351.

    CAS  PubMed  Google Scholar 

  130. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR . Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006; 117: 1113–1121.

    Article  PubMed  Google Scholar 

  131. Dani C, Bertini G, Corsini I, Elia S, Vangi V, Pratesi S et al. The fate of ductus arteriosus in infants at 23–27 weeks of gestation: from spontaneous closure to ibuprofen resistance. Acta Paediatr 2008; 97: 1176–1180.

    Article  PubMed  Google Scholar 

  132. Nemerofsky SL, Parravicini E, Bateman D, Kleinman C, Polin RA, Lorenz JM . The ductus arteriosus rarely requires treatment in infants >1000 grams. Am J Perinatol 2008; 25: 661–666.

    Article  PubMed  Google Scholar 

  133. Herrman K, Bose C, Lewis K, Laughon M . Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed 2009; 94: F48–F50.

    Article  CAS  PubMed  Google Scholar 

  134. Gonzalez A, Sosenko IR, Chandar J, Hummler H, Claure N, Bancalari E . Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996; 128: 470–478.

    Article  CAS  PubMed  Google Scholar 

  135. Adzick NS, Harrison MR, deLorimier AA . Surgical clip ligation of patent ductus arteriosus in premature infants. J Pediatr Surg 1986; 21: 158.

    Article  CAS  PubMed  Google Scholar 

  136. McNamara PJ, Sehgal A . Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed 2007; 92: F424–F427.

    Article  PubMed  PubMed Central  Google Scholar 

  137. Nelson DP, Schwartz SM, Chang AC . Neonatal physiology of the functionally univentricular heart. Cardiol Young 2004; 14 (Suppl 1): 52–60.

    Article  PubMed  Google Scholar 

  138. Lister G, Hellenbrand WE, Kleinman CS, Talner NS . Physiologic effects of increasing hemoglobin concentration in left-to-right shunting in infants with ventricular septal defects. N Engl J Med 1982; 306: 502–506.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA

    W E Benitz

Authors
  1. W E Benitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W E Benitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benitz, W. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis?. J Perinatol 30, 241–252 (2010). https://doi.org/10.1038/jp.2010.3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2010.3

Keywords

This article is cited by

Search

Advanced search

Quick links